Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, November 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Improved Method for Protein Quality Control
Friday, October 31, 2014
Separation of intact monoclonal antibody sialylation isoforms by pH gradient ion-exchange chromatography.

Randox Launches World’s Most Comprehensive Third Party Haematology Control
Wednesday, October 29, 2014
Randox Laboratories has launched a third party multi-analyte haematology control; the most comprehensive haematology quality control (QC) solution on the market to date.

Bulldog Bio Provides Novel Adjuvant Enhancer for Improved Vaccinations
Tuesday, October 28, 2014
New Opticcine Adjuvant Enhancer improves immune response against a wide variety of antigens.

PerkinElmer Launches Mantra™ Quantitative Pathology Imaging System
Tuesday, October 28, 2014
New imaging system enables researchers to visualize, quantify, analyze and phenotype multiple types of immune cells simultaneously in solid tumors.

Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

TxCell to Present on T Cellular Therapy for Autoimmune Diseases
Thursday, October 16, 2014
Dr. Miguel Forte will present at the 7th National Bio-Therapy Conference 2014, China.

Gyros Launches Gyrolab Protein A Kit for Efficient Quantification of Residual Protein A
Wednesday, October 08, 2014
Optimized kit for use with Gyros immunoassay platform.

Novosanis and University of Antwerp Receive Prestigious James Dyson Award
Tuesday, September 23, 2014
Company receives award as a national winner for its VAX-ID device.

Delenex Therapeutics AG Expands Pipeline
Tuesday, September 16, 2014
Extremely high potency and small size uniquely position products in dermatological and inflammatory diseases.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 362
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv